Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | cytochrome P450 reductase | 0.0108 | 0.2933 | 0.7846 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0108 | 0.2933 | 0.7839 |
Mycobacterium ulcerans | diaminopimelate decarboxylase LysA | 0.0124 | 0.3742 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0108 | 0.2933 | 0.7344 |
Trichomonas vaginalis | ornithine decarboxylase, putative | 0.0124 | 0.3742 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0108 | 0.2933 | 0.7344 |
Chlamydia trachomatis | sulfite reductase | 0.0066 | 0.0912 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0251 | 1 | 1 |
Toxoplasma gondii | diaminopimelate decarboxylase | 0.0124 | 0.3742 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0108 | 0.2933 | 0.5 |
Plasmodium vivax | S-adenosylmethionine decarboxylase-ornithine decarboxylase, putative | 0.0124 | 0.3742 | 1 |
Entamoeba histolytica | ornithine decarboxylase, putative | 0.0124 | 0.3742 | 0.5 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0122 | 0.3664 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.0108 | 0.2933 | 0.5 |
Plasmodium falciparum | S-adenosylmethionine decarboxylase/ornithine decarboxylase | 0.0124 | 0.3742 | 1 |
Mycobacterium leprae | PROBABLE DIAMINOPIMELATE DECARBOXYLASE LYSA (DAP DECARBOXYLASE) | 0.0048 | 0 | 0.5 |
Trypanosoma brucei | ornithine decarboxylase | 0.0124 | 0.3742 | 1 |
Giardia lamblia | Ornithine decarboxylase | 0.0124 | 0.3742 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0108 | 0.2933 | 0.7344 |
Brugia malayi | flavodoxin family protein | 0.0108 | 0.2933 | 0.2224 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0108 | 0.2933 | 0.7344 |
Mycobacterium tuberculosis | Diaminopimelate decarboxylase LysA (DAP decarboxylase) | 0.0124 | 0.3742 | 0.5 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0108 | 0.2933 | 0.4262 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0054 | 0.0311 | 0.0118 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0066 | 0.0912 | 0.1889 |
Trichomonas vaginalis | pyridoxal-dependent decarboxylase, putative | 0.0124 | 0.3742 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0108 | 0.2933 | 0.2224 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0095 | 0.2332 | 0.6233 |
Brugia malayi | Pyridoxal-dependent decarboxylase, pyridoxal binding domain containing protein | 0.0124 | 0.3742 | 0.3114 |
Schistosoma mansoni | lipoxygenase | 0.0086 | 0.1854 | 0.4666 |
Schistosoma mansoni | lipoxygenase | 0.0122 | 0.3664 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0251 | 1 | 1 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0122 | 0.3664 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0108 | 0.2933 | 0.5 |
Loa Loa (eye worm) | pyridoxal-dependent decarboxylase | 0.0124 | 0.3742 | 0.3114 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.2933 | 0.2224 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0108 | 0.2933 | 0.4262 |
Trichomonas vaginalis | ornithine decarboxylase, putative | 0.0124 | 0.3742 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0108 | 0.2933 | 0.2224 |
Leishmania major | ornithine decarboxylase, putative | 0.0124 | 0.3742 | 1 |
Onchocerca volvulus | 0.0124 | 0.3742 | 0.5 | |
Trichomonas vaginalis | diaminopimelate decarboxylase, putative | 0.0124 | 0.3742 | 1 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0108 | 0.2933 | 0.5 |
Trichomonas vaginalis | diaminopimelate decarboxylase, putative | 0.0124 | 0.3742 | 1 |
Leishmania major | p450 reductase, putative | 0.0108 | 0.2933 | 0.4262 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.